The effect of a transient premature luteinizing hormone surge without elevated serum progesterone on in vitro fertilization outcomes in a gonadotropin-releasing hormone antagonist flexible protocol

References

• Barri PN, Coroleu B, Martinez F, et al. Stimulation protocols for poor responders and aged women. Mol Cell Endocrinol. 2000;166(1):15–20.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Wang J, Liu L, et al. Effects of high progesterone level on the day of human chorionic gonadotrophin administration in in vitro fertilization cycles on epigenetic modification of endometrium in the peri-implantation period. Fertil Steril. 2017;108(2):269–276.e1.
   PubMed Web of Science ®Google Scholar
• Healy MW, Yamasaki M, Patounakis G, et al. The slow growing embryo and premature progesterone elevation: compounding factors for embryo-endometrial asynchrony. Hum Reprod. 2017;32(2):362–367.
   PubMed Web of Science ®Google Scholar
• Lee TH, Lin YH, Seow KM, et al. Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial. Fertil Steril. 2008;90(1):113–120.
   PubMed Web of Science ®Google Scholar
• Allegra A, Marino A, Coffaro F, et al. GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial. Hum Reprod. 2007;22(1):101–108.
   PubMed Web of Science ®Google Scholar
• Lambalk CB, Leader A, Olivennes F, et al. Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Hum Reprod. 2006;21(3):632–639.
   PubMed Web of Science ®Google Scholar
• Lainas T, Zorzovilis J, Petsas G, et al. In a flexible antagonist protocol, earlier, criteria-based initiation of GnRH antagonist is associated with increased pregnancy rates in IVF. Hum Reprod. 2005;20(9):2426–2433.
   PubMed Web of Science ®Google Scholar
• Lundin K, Ahlstrom A. Quality control and standardization of embryo morphology scoring and viability markers. Reprod Biomed. 2015;31(4):459–471.
   PubMed Web of Science ®Google Scholar
• Tiboni GM, Palumbo P, Leonzio E, et al. Effectiveness of a low gonadotrophin-releasing hormone antagonist dose in preventing premature luteinizing hormone rise during controlled ovarian stimulation. Gynecol Endocrinol. 2011;27(11):885–889.
   PubMed Web of Science ®Google Scholar
• Kolibianakis EM, Venetis CA, Kalogeropoulou L, et al. Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial. Fertil Steril. 2011;95(2):558–562.
   PubMed Web of Science ®Google Scholar
• Mochtar MH. The effect of an individualized GnRH antagonist protocol on folliculogenesis in IVF/ICSI. Hum Reprod. 2004;19(8):1713–1718.
   PubMed Web of Science ®Google Scholar
• Kolibianakis EM, Albano C, Kahn J, et al. Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. Fertil Steril. 2003;79(4):873–880.
   PubMed Web of Science ®Google Scholar
• Bonduelle M, Oberye J, Mannaerts B, et al. Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation. Hum Reprod. 2010;25(6):1433–1440.
   PubMed Web of Science ®Google Scholar
• Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod. 2001;16(4):644–651.
   PubMed Web of Science ®Google Scholar
• Fluker M, Grifo J, Leader A, et al. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril. 2001;75(1):38–45.
   PubMed Web of Science ®Google Scholar
• Choi MH, Cha SH, Park CW, et al. The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day in in vitro fertilization-embryo transfer cycles. Clin Exp Reprod Med. 2013;40(2):90–94.
   PubMedGoogle Scholar
• Lin YH, Seow KM, Chen HJ, et al. Effect of cetrorelix dose on premature LH surge during ovarian stimulation. Reprod Biomed. 2008;16(6):772–777.
   PubMed Web of Science ®Google Scholar
• Gridelet V, Tsampalas M, Berndt S, et al. Evidence for cross-talk between the LH receptor and LH during implantation in mice. Reprod Fertil Dev. 2013;25(3):511–522.
   PubMed Web of Science ®Google Scholar
• Sacchi S, Sena P, Degli Esposti C, et al. Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium. J Assist Reprod Genet. 2018;35(9):1703–1712.
   PubMed Web of Science ®Google Scholar
• Mishra S, Lei ZM, Rao CV. A novel role of luteinizing hormone in the embryo development in cocultures. Biol Reprod. 2003;68(4):1455–1462.
   PubMed Web of Science ®Google Scholar
• Messinis IE. Ovarian feedback, mechanism of action and possible clinical implications. Hum Reprod. 2006;12(5):557–571.
   Web of Science ®Google Scholar
• Kummer NE, Weitzman VN, Benadiva CA, et al. In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle. Fertil Steril. 2011;95(8):2592–2594.
   PubMed Web of Science ®Google Scholar
• Venetis CA, Kolibianakis EM, Papanikolaou E, et al. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod. 2007;13(4):343–355.
   Web of Science ®Google Scholar
• Oktem O, Akin N, Bildik G, et al. FSH Stimulation promotes progesterone synthesis and output from human granulosa cells without luteinization. Hum Reprod. 2017;32(3):643–652.
   PubMed Web of Science ®Google Scholar
• Venetis CA, Kolibianakis EM, Bosdou JK, et al. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Hum Reprod. 2015;30(3):684–691.
   PubMed Web of Science ®Google Scholar
• Racca A, Santos-Ribeiro S, De Munck N, et al. Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: is there a deleterious effect on embryo quality? Hum Reprod. 2018;33(5):860–868.
   PubMed Web of Science ®Google Scholar